The historical rank and industry rank for Eiko Lifesciences's FCF Margin % or its related term are showing as below:
BOM:540204'
s FCF Margin % Range Over the Past 10 Years
Min: -86.1 Med: -13.41 Max: 21.83
Current: 4.33
During the past 13 years, the highest FCF Margin % of Eiko Lifesciences was 21.83%. The lowest was -86.10%. And the median was -13.41%.
BOM:540204's FCF Margin % is ranked better than 60.6% of 1576
companies
in the Chemicals industry
Industry Median: 1.855
vs BOM:540204: 4.33
Eiko Lifesciences FCF Margin % Related Terms
Eiko Lifesciences FCF Margin % Historical Data
* Premium members only.
The historical data trend for Eiko Lifesciences's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540204 vs LIN, SHW, ECL: FCF Margin % Comparison
For the Specialty Chemicals subindustry, Eiko Lifesciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eiko Lifesciences FCF Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Eiko Lifesciences's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Eiko Lifesciences's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eiko Lifesciences (BOM:540204) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Eiko Lifesciences and its competitors. According to the industry distribution chart, Eiko Lifesciences ranks #621 out of 1576 companies in the Chemicals industry, placing it in the top 39.4%.
Is Eiko Lifesciences' FCF Margin % too high?
Eiko Lifesciences' current FCF Margin % is 0.00%. Based on the distribution chart, Eiko Lifesciences ranks #621 out of 1576 companies in the Chemicals industry, which is above the industry midpoint. Overall, Eiko Lifesciences has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eiko Lifesciences' FCF Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Eiko Lifesciences ranks #621 out of 1576 companies for FCF Margin %. This puts Eiko Lifesciences in the upper half of its industry. The industry median FCF Margin % is 1.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Chemicals company?
The median FCF Margin % among Chemicals companies is 1.86, based on 1,576 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Eiko Lifesciences and its competitors. For the Chemicals industry, the median FCF Margin % is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eiko Lifesciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiko Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Eiko Lifesciences (BOM:540204) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹78.58, compared to a current price of ₹49.72 — trading 36.7% below its estimated fair value. The current FCF Margin % is 0.00%. Eiko Lifesciences' overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Eiko Lifesciences (BOM:540204), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eiko Lifesciences (BOM:540204) Overvalued in 2026?
Based on GuruFocus' analysis, Eiko Lifesciences stock appears to be undervalued.
The current stock price of ₹49.72 is trading 36.7% below its estimated GF Value™ of ₹78.58.
GuruFocus considers Eiko Lifesciences to be Significantly Undervalued.
Key valuation signals for BOM:540204:
FCF Margin %: 0.00%
GF Value™: ₹78.58 vs. price of ₹49.72 (36.7% below fair value)
No single metric tells the full story. See the BOM:540204 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eiko Lifesciences Ltd is a manufacturer, supplier, and exporter of specialty chemicals, fine chemicals, and pharma intermediates.. The company's segment includes Agrochemicals, Oleo Chemicals, Pharmaceuticals, Food Additives, clinical research, development, and Logistics. Geographically, the company generates the majority of its revenue from the Domestic market.
78GF Score
Get the complete analysis for BOM:540204
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540204 has been successfully added to your 
